SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-021629
Filing Date
2021-11-04
Accepted
2021-11-04 09:11:09
Documents
70
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sgmo-20210930.htm   iXBRL 10-Q 1670245
2 EX-10.1 sgmo-20210930xex101_employ.htm EX-10.1 37393
3 EX-31.1 sgmo-20210931xex311.htm EX-31.1 10159
4 EX-31.2 sgmo-20210930xex312.htm EX-31.2 10274
5 EX-32.1 sgmo-20210930xex321.htm EX-32.1 7232
11 GRAPHIC sgmo-20210930_g1.jpg GRAPHIC 47881
12 GRAPHIC sgmo-20210930_g2.jpg GRAPHIC 136221
  Complete submission text file 0001628280-21-021629.txt   8135369

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20210930.xsd EX-101.SCH 57660
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgmo-20210930_cal.xml EX-101.CAL 74071
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgmo-20210930_def.xml EX-101.DEF 292360
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20210930_lab.xml EX-101.LAB 571797
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20210930_pre.xml EX-101.PRE 411226
13 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20210930_htm.xml XML 1367783
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30171 | Film No.: 211378459
SIC: 2836 Biological Products, (No Diagnostic Substances)